Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 3,585.00
+90.00 (2.58%)
At close: Nov 13, 2026
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 25.16 billion as of November 13, 2026. It is the 37,319th most valuable company in the world and the 2,262nd biggest in South Korea. Its market cap has decreased by 25.39% in one year.
Market Cap
25.16B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,262 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 25.16B, a decrease of -69.62%. That is a compound annual growth rate of -24.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 25.16B | -25.00% |
| Dec 30, 2025 | 33.55B | 11.42% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 32.67B |
| Korean Drug | 31.15B |
| HLscience | 31.07B |
| Korea Arlico Pharm | 29.41B |
| Kyung Nam Pharm | 29.08B |
| Pharmsville | 25.85B |
| Seoul Pharma | 20.96B |
| Daesung Microbiological Labs. | 19.80B |